|
Originally published In Press as doi:10.1074/jbc.M401891200 on April 20, 2004
J. Biol. Chem., Vol. 279, Issue 29, 30259-30264, July 16, 2004
Effects of Neprilysin Chimeric Proteins Targeted to Subcellular Compartments on Amyloid Peptide Clearance in Primary Neurons*
Emi Hama,
Keiro Shirotani,
Nobuhisa Iwata, and
Takaomi C. Saido
From the
Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
Neprilysin (NEP) is a rate-limiting amyloid peptide (A )-degrading enzyme in the brain. We demonstrated previously that overexpression of neprilysin in primary cortical neurons remarkably decreased not only extracellular but also intracellular A levels. To investigate the subcellular compartments where neprilysin degrades A most efficiently, we expressed neprilysin chimeric proteins containing various subcellular compartment-targeting domains in neurons. Sec12-NEP, -galactoside 2,6-sialyltransferase-NEP, transferrin receptor-NEP, and growth-associated protein 43-NEP were successfully sorted to the endoplasmic reticulum, trans-Golgi network, early/recycling endosomes, and lipid rafts, respectively. We found that intracellularly, wild-type neprilysin and all the chimeras showed equivalent A 40-degrading activities. A 40 was more effectively cleared than A 42, and this tendency was greater for intracellular A than for extracellular A . Wild-type and trans-Golgi network-targeted ST-NEP cleared more intracellular A 42 than the other chimeras. Wild-type neprilysin cleared extracellular A more effectively than any of the chimeras, among which endoplasmic reticulum-targeted Sec12-NEP was the least effective. These observations indicate that different intracellular compartments may be involved in the metabolism of distinct pools of A (A 40 and A 42) to be retained or recycled intracellularly and to be secreted extracellularly, and that the endogenous targeting signal in wild-type neprilysin is well optimized for the overall neuronal clearance of A .
Received for publication, February 20, 2004
, and in revised form, March 26, 2004.
* This work was supported by research grants from RIKEN Brain Science Institute and the Ministry of Education, Culture, Sports, Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-48-467-9715; Fax: 81-48-467-9716; E-mail: saido{at}brain.riken.go.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. J. Meilandt, M. Cisse, K. Ho, T. Wu, L. A. Esposito, K. Scearce-Levie, I. H. Cheng, G.-Q. Yu, and L. Mucke
Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic A{beta} Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice
J. Neurosci.,
February 18, 2009;
29(7):
1977 - 1986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Iijima-Ando, S. A. Hearn, L. Granger, C. Shenton, A. Gatt, H.-C. Chiang, I. Hakker, Y. Zhong, and K. Iijima
Overexpression of Neprilysin Reduces Alzheimer Amyloid-{beta}42 (A{beta}42)-induced Neuron Loss and Intraneuronal A{beta}42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in Drosophila
J. Biol. Chem.,
July 4, 2008;
283(27):
19066 - 19076.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|